Condition (MeSH)
Focal Nodular Hyperplasia
ClinicalTrials.gov lists 7 trials for Focal Nodular Hyperplasia or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Focal Nodular Hyperplasia itself; the rest are tagged with a narrower condition beneath it.
When did Focal Nodular Hyperplasia trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2018 | 1 |
| 2016 | 1 |
| 2013 | 1 |
| 2009 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Focal Nodular Hyperplasia trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 3 |
| Observational | 4 |
How many Focal Nodular Hyperplasia trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Completed | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Focal Nodular Hyperplasia? (19)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Contrast-Enhanced Ultrasound Compared With Hepatobiliary Agent MRI for Differentiation of Focal Nodular Hyperplasia and Hepatic Adenoma: A Prospective Trial. | Ultrasound quarterly | 2024 | Yes |
| Benign liver tumours: understanding molecular physiology to adapt clinical management. | Nature reviews. Gastroenterology & hepatology | 2022 | Yes |
| Contrast-enhanced ultrasound for the assessment of focal nodular hyperplasia - results of a multicentre study. | Medical ultrasonography | 2021 | Yes |
| Liver elastography malignancy prediction score for noninvasive characterization of focal liver lesions. | Liver international : official journal of the International Association for the Study of the Liver | 2018 | Yes |
| Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact. | Annals of surgical oncology | 2015 | Yes |
Showing 5 of 19 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.